Table 1 The demographic characteristics and medication use of patients at baseline
From: Do biologic therapies reduce aortic inflammation in rheumatoid arthritis patients?
Clinical characteristics | Values |
|---|---|
Age (years) | 58.4 ± 13.8 |
Female/male | 49/15 |
Disease duration (years) | 13.1 ± 11.8 |
BMI | 21.8 ± 4.0 |
Smoking, n (%) | 8 (12.7) |
Hypertension, n (%) | 23 (36.5) |
Diabetes, n (%) | 6 (9.7) |
Total cholesterol (mg/dL) | 197.4 ± 39.3 |
LDL (mg/dL) | 114.9 ± 37.5 |
HDL (mg/dL) | 59.6 ± 15.0 |
Triglycerides (mg/dL) | 108.2 ± 46.0 |
PSL use, n (%) | 31 (48.4) |
PSL dose (mg/day) | 2.0 ± 2.3 |
MTX use, n (%) | 45 (70.3) |
MTX dose (mg/week) | 5.7 ± 3.5 |
Biologics (IFX/ETN/ADA/GLM/TCZ/ABT) | 18/14/16/2/13/1 |